{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-335150","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2026-08-05T20:15:17+00:00","discovered_at":"2026-08-05T20:16:00.271260+00:00","generated_at":"2026-08-05T20:16:17.929319+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"RxSight Q2 revenue $33.7M, product sales down 19% YoY; withdraws 2026 guidance","bullets":["Product sales $27.2M (-19% YoY); LAL units 24,917; LDD units 12.","Net loss $(12.1)M ($(0.29)/share); adjusted net loss $(4.6)M ($(0.11)/share).","New CEO Aziz Mottiwala appointed; Alcon collaboration with up to $200M in payments.","Next-gen Light Adjustable Technology platform announced; 2026 guidance withdrawn.","Cash and investments $208.8M as of June 30, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-335150","json":"https://secwatch.observer/filing/0001193125-26-335150.json","markdown":"https://secwatch.observer/filing/0001193125-26-335150.md","text":"https://secwatch.observer/filing/0001193125-26-335150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526335150/0001193125-26-335150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526335150/rxst-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:16:17.929319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}